Standout Papers
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients (2015)
- Immunotherapy in breast cancer: an overview of current strategies and perspectives (2023)
- Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer (2022)
- Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer (2024)
Immediate Impact
13 by Nobel laureates 14 from Science/Nature 97 standout
Citing Papers
Natural killer cell therapies
2024 StandoutNature
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
2023 Standout
Works of Emanuela Romano being referenced
Phase 1/2 Study of DF1001, a novel tri-specific, NK cell engager therapy targeting HER2, in patients with advanced solid tumors: Phase 1 DF1001 monotherapy dose-escalation results.
2023
Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Emanuela Romano | 2631 | 2038 | 1136 | 65 | 3.9k | |
| Ester Simeone | 3111 | 1576 | 1447 | 113 | 4.3k | |
| Chantale Bernatchez | 2327 | 1821 | 997 | 91 | 3.3k | |
| Jean‐François Baurain | 1602 | 1398 | 1071 | 101 | 3.3k | |
| Eddy C. Hsueh | 2931 | 2429 | 1533 | 95 | 4.9k | |
| Zeynep Eroglu | 2720 | 1043 | 1182 | 123 | 3.5k | |
| Tara C. Gangadhar | 2933 | 1726 | 1014 | 75 | 3.9k | |
| Kimberly R. Kalli | 2012 | 1620 | 2125 | 100 | 5.3k | |
| Elisa A. Rozeman | 2033 | 1264 | 930 | 63 | 2.9k | |
| Els M.E. Verdegaal | 1593 | 1554 | 1129 | 60 | 3.0k | |
| Tobias Schatton | 3058 | 1354 | 2180 | 40 | 4.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...